E-mail Print PDF


Derré L, Ferber M, Touvrey C, Devevre E, Zoete V, Leimgruber A, Romero P, Michielin O, Lévy F, Speiser DE.
A novel population of human melanoma-specific CD8 T cells recognizes Melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide.
J Immunol., 2007 Dec 1;179(11):7635-45.

Stupp R, Pica A, Mirimanoff RO, Michielin O.
A practical guide for the management of gliomas
Bull Cancer., 2007, 94(9), 817-22

Michielin O.
Application of molecular modelling to new therapeutic cancer approaches
Bull Cancer. 2007 Sep 1;94(9):763-8

Feige JN, Gelman L, Rossi D, Zoete V, Metivier R, Tudor C, Anghel SI, Grosdidier A, Lathion C, Engelborghs Y, Michielin O, Wahli W, Desvergne B.
The endocrine disruptor mono-ethyl-hexyl-phthalate is a selective PPARgamma modulator which promotes adipogenesis
J Biol Chem, 2007, 282(26), 19152-66

Alves PM, Viatte S, Fagerberg T, Michielin O, Bricard G, Bouzourene H, Vuilleumier H, Kruger T, Givel JC, Lévy F, Speiser DE, Cerottini JC, Romero P.
Immunogenicity of the carcinoembryonic antigen derived peptide 694 in HLA-A2 healthy donors and colorectal carcinoma patients
Cancer Immunol. Immunother., 2007, 56(11), 1795-805

Zhang KL, Mangeat B, Ortiz M, Zoete V, Trono D, Telenti A, Michielin O.
Model Structure of Human APOBEC3G
PLoS ONE., 2007, 2(4), e378

Zoete V, Grosdidier A, Michielin O.
Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators
Biochim. Biophys. Acta, 2007, 1771(8), 915-25

Grosdidier A, Zoete V, Michielin O.
EADock: docking of small molecules into protein active sites with a multiobjective evolutionary optimization
Proteins, 2007, 67(4): 1010-25

Zoete V, Michielin O.
Comparison between computational alanine scanning and per-residue binding free energy decomposition for protein-protein association using MM-GBSA: application to the TCR-p-MHC complex
Proteins, 2007, 67(4): 1026-47

Michalik L, Zoete V, Krey G, Grosdidier A, Gelman L, Chodanowski P, Feige JN, Desvergne B, Wahli W, Michielin O.
Combined simulation and mutagenesis analyses reveal the involvement of key residues for peroxisome proliferator-activated receptor alpha helix 12 dynamic behavior
J. Biol. Chem., 2007, 282(13): 9666-77

Butticaz C, Michielin O, Wyniger J, Telenti A, Rothenberger S.
Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation
J. Virol., 2007, 81(3): 1502-5


google analytics